Showing results (671-680 of 759) with videos related to

Sort By:
Pageof 76
Advances in Therapy|December 9, 2024
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global RegistryNjira L Lugogo, Xavier Soler, Yasuhiro Gon, et al.
The American Journal of Psychiatry|April 19, 2023
Cerebral Small Vessel Disease Progression and the Risk of Dementia: A 14-Year Follow-Up StudyMina A Jacob, Mengfei Cai, Vera van de Donk, et al.
Allergy|July 28, 2022
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthmaAlberto Papi, Jonathan Corren, Mario Castro, et al.
ERJ Open Research|October 20, 2023
Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Allergy|July 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids doseIan D Pavord, Arnaud Bourdin, Alberto Papi, et al.
Stroke|October 30, 2025
Cholinergic Disruption Contributes to Motoric Cognitive Dysfunction in Cerebral Small Vessel DiseaseMengfei Cai, Hao Li, Milan Nemy, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitizationJonathan Corren, Nicola A Hanania, William W Busse, et al.
Respiratory Medicine|July 16, 2013
Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthmaA Cukier, C M A Jacob, N A Rosario Filho, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Respiratory Medicine|September 10, 2022
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baselineArnaud Bourdin, J Christian Virchow, Alberto Papi, et al.
Pageof 76